AMRX
Amneal Pharmaceuticals, Inc.
+0.32 (+1.74%)18.40USD1.0M成交股數5.9B市值38.3本益比(近四季)1.9股價營收比+9.9%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 796M+10% | 723M+4% | 814M+16% | 785M+12% | 725M+10% | 695M+13% | 702M+13% | 702M+17% | 659M | 617M | 620M | 599M |
| 營業成本 | 462M | 402M | 517M | 511M | 438M | 440M | 433M | 452M | 421M | 427M | 388M | 379M |
| 毛利 | 335M+17% | 320M+25% | 297M+10% | 274M+10% | 286M+20% | 256M+35% | 270M+16% | 250M+14% | 238M | 190M | 233M | 220M |
| 毛利率 | 42.0% | 44.3% | 36.5% | 34.9% | 39.5% | 36.8% | 38.4% | 35.6% | 36.1% | 30.8% | 37.5% | 36.7% |
| 研發費用 | 39.0M | 38.4M | 34.8M | 63.4M | 48.0M | 40.0M | 61.1M | 36.1M | 39.3M | 46.1M | 41.4M | 37.8M |
| 銷售管理費用 | 149M | 139M | 146M | 138M | 124M | 118M | 119M | 116M | 113M | 109M | 113M | 106M |
| 營業利益 | 130M+17% | 142M+41% | 112M+26% | 70.3M-26% | 111M-1136% | 100M+607% | 88.8M+17% | 95.5M+19% | −10.7M | 14.2M | 75.6M | 80.1M |
| 營業利益率 | 16.3% | 19.6% | 13.8% | 9.0% | 15.4% | 14.4% | 12.6% | 13.6% | -1.6% | 2.3% | 12.2% | 13.4% |
| 稅後淨利 | 57.7M+157% | 62.3M+411% | 35.1M-22585% | 2.4M-60% | 22.4M-124% | 12.2M-112% | −156K-102% | 6.0M-50% | −91.6M | −98.6M | 9.7M | 11.9M |
| 淨利率 | 7.2% | 8.6% | 4.3% | 0.3% | 3.1% | 1.8% | -0.0% | 0.9% | -13.9% | -16.0% | 1.6% | 2.0% |
| 稀釋 EPS | 0.18+157% | 0.19+375% | 0.10 | 0.01-50% | 0.07-123% | 0.04-107% | 0.00-100% | 0.02-75% | -0.30 | -0.57 | 0.06 | 0.08 |
| 稀釋股數 | 328M | 329M | 325M | 325M | 322M | 324M | 310M | 319M | 307M | 176M | 160M | 155M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 128M | 198M | 282M | 201M | 71.5M | 59.2M | 74.0M | 43.8M | 46.5M | 91.5M | 86.9M | 109M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 678M | 642M | 606M | 615M | 609M | 601M | 596M | 576M | 571M | 581M | 576M | 551M |
| 總資產 | 3.8B | 3.5B | 3.7B | 3.6B | 3.4B | 3.4B | 3.5B | 3.5B | 3.5B | 3.5B | 3.7B | 3.7B |
| 有息負債 | 2.6B | 2.6B | 2.6B | 2.6B | 2.1B | 2.2B | 2.2B | 2.2B | 2.4B | 2.4B | 2.5B | 2.5B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 33.0M | −45.4M | −70.8M | −109M | −112M | −132M | −93.4M | −57.5M | −63.7M | 19.8M | 331M | 318M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −2.4B | −2.4B | −2.3B | −2.4B | −2.1B | −2.1B | −2.1B | −2.1B | −2.3B | −2.3B | −2.5B | −2.4B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −26.7M-461% | – | – | – | 7.4M | – | – | −4.4M | – | – | – |
| 資本支出 | – | 8.2M | – | – | – | 13.2M | – | – | 9.2M | – | – | – |
| 自由現金流 | – | −34.9M+507% | – | – | – | −5.8M | – | – | −13.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -4.8% | – | – | – | -0.8% | – | – | -2.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.0B
| Affordable Medicines | 1.7B | 57.8% | +3.6% |
|---|---|---|---|
| Av KARE | 745M | 24.7% | +12.3% |
| Specialty | 529M | 17.5% | +18.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.0B | +8.0% | 72.1M | 2.4% | 0.22 | 270M |
| FY2024 | 2.8B | +16.7% | −117M | -4.2% | -0.38 | 243M |
| FY2023 | 2.4B | +8.2% | −84.0M | -3.5% | -0.48 | 302M |
| FY2022 | 2.2B | +5.7% | −271M | -12.2% | -0.86 | 18.7M |
| FY2021 | 2.1B | +5.1% | 13.2M | 0.6% | 0.07 | 194M |
| FY2020 | 2.0B | +22.5% | 67.8M | 3.4% | 0.61 | 323M |
| FY2019 | 1.6B | -2.2% | −604M | -37.1% | -2.74 | −45.5M |
| FY2018 | 1.7B | – | −19.7M | -1.2% | -0.16 | 167M |